What Is Precision Medicine?
Precision medicine, also called personalized medicine, means giving healthcare that is specially designed for each person. Precision medicine means using information about a person’s genes, lifestyle, environment, and health history to decide the best treatment. Instead of treating everyone the same, doctors choose the care that best fits each person.
Precision medicine uses special tests like genetic testing and molecular profiling to look at a person’s genes, proteins, and other biomarkers. This helps doctors find genetic changes that may affect disease risk or how a patient responds to treatment.
Precision medicine helps doctors make accurate diagnoses and provide targeted, personalized treatments by understanding the genetic and molecular causes of a disease. It helps them choose medicines that work better, predict potential side effects, and adjust doses for better results.
What Is Lung Cancer?
The CDC (Centers for Disease Control and Prevention) defines lung cancer as a type of cancer that begins in the lungs. It is one of the most common and deadly types of cancer worldwide. Lung cancer occurs when abnormal cells of the lungs grow uncontrollably, forming a tumor.
Over time, these cancer cells can invade nearby tissues and spread to other parts of the body through the bloodstream or lymphatic system. Smoking tobacco is attributed as the leading cause of lung cancers reported worldwide.
In addition, second-hand smoke and various environmental and occupational factors also contribute significantly to the increase in the number of lung cancer cases.
What Is the Importance of Precision Medicine in Lung Cancer Therapy?
Precision medicine is very important in lung cancer treatment because it helps doctors choose the best treatment for each patient.
Targeted Treatments: Precision medicine finds specific genetic mutations or molecular features in lung cancer cells. This helps doctors use targeted therapies that block the activity of these mutations.
Personalized Approach: Precision medicine creates individual treatment plans by studying a patient’s genetic and molecular characteristics. This approach may lead to better outcomes and improved survival rates.
Early Detection and Prevention: Genetic testing can identify people who have a higher risk of developing lung cancer. This enables earlier detection and preventive measures, which can improve treatment outcomes.
Combating Drug Resistance: Precision medicine helps doctors understand how cancer becomes resistant to certain drugs. This allows them to change treatments or develop new strategies to improve the therapy's effectiveness.
Reduced Side Effects: Precision medicine reduces unnecessary treatments, thereby lowering side effects and improving the quality of life for lung cancer patients.
What Are the Advances in Precision Medicine for Lung Cancer Patients?
The various approaches in precision medicine are as follows:
1. Immunotherapy Predictive Markers: Tumor immunotherapy for lung cancer uses checkpoint inhibitors such as CTLA-4, PD-1, and PD-L1 inhibitors. These treatments have shown promising results in many cancers, but challenges remain in selecting the right drugs and identifying markers to predict how well the treatment will work. PD-L1 expression is a commonly used predictive marker, but it is not definitive, as some PD-L1-negative patients still respond to immunotherapy, while some PD-L1-positive patients do not.
2. Liquid Biopsy: Tumors can be different in different parts of the body, so it is difficult to get all the needed information from one tissue biopsy. It is also not possible to sample every tumor in the body. To address this problem, liquid biopsy has been developed as a non-invasive method for detecting cancer and monitoring disease progression.
Liquid biopsy detects circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and other biomarkers in blood or other body fluids. Compared to traditional tissue biopsy, liquid biopsy is less invasive and carries a lower risk. It has great potential for cancer diagnosis and monitoring, but more research and standardization are still needed to improve its accuracy and effectiveness.
3. Patient-Based Xenograft Models: Patient-derived xenograft (PDX) tumor models are used to study how tumors grow and respond to treatment. They help researchers test different drugs and assess how well they work, supporting the development of more personalized treatments for patients.
PDX models can be created not only from tumor tissue samples but also from circulating tumor cells (CTCs) found in the blood or from tumor cells collected from malignant pleural effusions. With the support of advanced biomedical technologies, PDX models have strong potential to predict treatment response and prognosis in lung cancer patients.
4. Artificial Intelligence (AI) Approaches: AI technology helps make cancer treatment more personalized by supporting tumor precision therapy. It also improves early lung cancer screening by making it faster and more accurate. In addition, AI helps doctors analyze medical images and pathology results, thereby improving lung cancer detection. AI technology can also assess how a patient responds to treatment and predict outcomes, such as survival, cancer spread (metastasis), and the risk of the cancer coming back (recurrence). AI is widely used in surgery, particularly in robotic-assisted procedures such as those performed with the da Vinci robot, which enable quick, less invasive operations.
Conclusion:
The discipline of oncology has undergone a revolution due to developments in precision medicine for patients with lung cancer. With a tailored strategy, treatment results, survival rates, and side effects have all improved. Precision medicine also plays an important role in early diagnosis of lung cancer, its prevention, and the management of treatment resistance.
As science and technology continue to advance, precision medicine has great potential to make lung cancer treatment more effective and personalized, helping improve patients' lives. If you need more information about how precision medicine can help treat lung cancer, consult a cancer specialist.
Key Takeaways:
Precision medicine is a modern approach to treating people by using information about their genes, environment, and lifestyle to help prevent disease and choose the best treatment.
Precision medicine is important in lung cancer treatment because it matches therapies to specific genetic mutations and molecular features of the tumor instead of using the same treatment for all patients.
Precision medicine for lung cancer has improved a lot by using targeted therapies, immunotherapy, and liquid biopsies to monitor the disease.
This approach can improve survival rates, reduce side effects, and enhance the effectiveness of targeted therapies.
Advances in precision medicine help doctors choose the best treatment for each lung cancer patient and improve outcomes.
